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Abstract The high-throughput - next generation sequenc-
ing (HT-NGS) technologies are currently the hottest topic in
the field of human and animals genomics researches, which
can produce over 100 times more data compared to the
most sophisticated capillary sequencers based on the Sanger
method. With the ongoing developments of high throughput
sequencing machines and advancement of modern bio-
informatics tools at unprecedented pace, the target goal of
sequencing individual genomes of living organism at a cost
of $1,000 each is seemed to be realistically feasible in the
near future. In the relatively short time frame since 2005,
the HT-NGS technologies are revolutionizing the human
and animal genome researches by analysis of chromatin
immunoprecipitation coupled to DNA microarray (ChIP-
chip) or sequencing (ChIP-seq), RNA sequencing (RNA-
seq), whole genome genotyping, genome wide structural
variation, de novo assembling and re-assembling of
genome, mutation detection and carrier screening, detection
of inherited disorders and complex human diseases, DNA
library preparation, paired ends and genomic captures,
sequencing of mitochondrial genome and personal
genomics. In this review, we addressed the important
features of HT-NGS like, first generation DNA sequencers,
birth of HT-NGS, second generation HT-NGS platforms,
third generation HT-NGS platforms: including single
molecule Heliscope™, SMRT™ and RNAP sequencers,
Nanopore, Archon Genomics X PRIZE foundation, com-
parison of second and third HT-NGS platforms, applica-
tions, advances and future perspectives of sequencing
technologies on human and animal genome research.
Keywords CHIP-chip.Chip-seq.De novo assembling.
High-throughput next generation sequencing.Personal
genomics.Re-sequencing.RNA-seq
Introduction
The completion of the first human genome drafts (Yamey
2000) was just a start of the modern DNA sequencing era
which resulted in further invention, improved development
toward new advanced strategies of high-throughput DNA
sequencing, so called the “high-throughput next generation
sequencing” (HT-NGS). These developed HT-NGS strate-
gies addressed our anticipated future needs of throughput
sequncing and cost, in a way which enabled its potential
multitude of current and future applications in mammalian
genomic research. Additionally in these advanced labora-
tory methodologies, a scope of new generation of bio-
informatics tools has further emerged as an essential
prerequisite to accommodate further strategic development
and improvement of output results. The HT-NGS is one of
the great challenges of today’s genomic research. For the
future direction, we need the in-depth genome sequence
information and analysis for most of the mammals,
including human to fully understand genome variation of
economic traits, genetic susceptibility to diseases, and
pharmacogenomics of drug response. The leading genome
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these are the core enabling goals for the next decade
genomics research. The National Human Genome Research
Institute (NHGRI) has echoed this need through its vision
for genomics research (Collins et al. 2003). The NHGRI
has categorized new sequencing approaches into those that
offer near-term and revolutionary benefits with a 100-fold
cost reduction per base pair (bp) within the next five years.
To extend the near-term, i.e., of within the next 5–10 years,
the revolutionary benefits should advance the field with a
10,000-fold cost reduction per base pair which in turn to
attain the “US$ 1000 genome”.
Year 2011 is celebrated as the 10th anniversary since the
human genome was first sequenced (www.nature.com/
natureconferences/hg10years/index.html). During this peri-
od, tremendous success has been achieved in the fields of
decoding of human genome, technological advancement of
new era of human genome applications, toward personal-
ized genomes and discovery of rare variants, leveraging
genome sequencing to impact on cancer researches and
mammalian evolution and population structure. The past
decade has witnessed a revolution in the field of human
genomics research. Today, a more global approach is being
embraced which has not only given a rise to the field of
systems biology, but has also touched all areas of biological
and medical research, as well as bringing them closer
together and blurring the lines that previously defined them
as individual disciplines of research. The horizons and
expectations have broadened due to the technological
advances in the field of genomics, especially the HT-NGS
and its wide range of applications such as: chromatin
immunoprecipitation coupled to DNA microarray (ChIP-
chip) or sequencing (ChIP-seq), RNA sequencing (RNA-
seq), whole genome genotyping, de novo assembling and
re-assembling of genome, genome wide structural variation,
mutation detection and carrier screening, detection of
inherited disorders and complex human diseases, DNA
library preparation, paired ends and genomic captures,
sequencing of mitochondrial genome and personal
genomics (for the detailed description, see: Table 2).
Besides the advancement of sequencing techniques, the
past decade will be remembered as the decade of the
genome research. Since the publications of first composite
genomes of human (Lander et al. 2001; Venter et al. 2001)-
many draft genomes from other organisms have been
published (www.ensembl.org/info/about/species.html). The
speed with which new genomes can now be sequenced has
been facilitated by the development of potential HT-NGS
technologies and assembly methods. It is now possible to
assemble de novo a large genome, a good example can be
derived from the recent genome assembly of the giant
panda (Li et al. 2010b) which utilized the only short reads
provided by next-generation DNA sequencing.
First generation DNA sequencers
Historically in 1975, the Sanger introduced the concept of
DNA sequencing method in his pioneered Croonian lecture
(Sanger 1975) and later on, published a rapid method for
determining sequences in DNA by primed synthesis with
DNA polymerase (Sanger and Coulson 1975). In the year
of 1977, two landmark articles for DNA sequencing were
published, i.e., the Frederick Sanger’s enzymatic dideoxy
DNA sequencing technique based on the chain-terminating
dideoxynucleotide analogues (Sanger et al. 1977) and the
Allan Maxam and Walter Gilbert’s chemical degradation
DNA sequencing technique in which terminally labeled
DNA fragments were chemically cleaved at specific bases
and separated by gel electrophoresis (Maxam and Gilbert
1977). These two prominent elite laboratories were respon-
sible for the introduction of the first automated DNA
sequencers led by Caltech (Smith et al. 1986), which was
subsequently commercialized by Applied Biosystems
(ABI), the European Molecular Biology Laboratory
(EMBL) (Ansorge et al. 1986, 1987) and Pharmacia-
Amersham, later General Electric (GE) healthcare. This
refinement and commercialization of the sequencing meth-
od led to its broad dissemination throughout the global
research community.
In the first automated fluorescent DNA sequencing
equipment, a complete gene locus for the hypoxanthine-
guanine phosphoribosyltransferase (HPRT) gene was se-
quenced, using for the first time the paired-end sequencing
approach (Edwards et al. 1990). In 1996, ABI introduced
the first commercial DNA sequencer that utilized a slab gel
electrophoresis by the ABI Prism 310. Two years later, the
considerable labor of pouring slab gels was replaced with
automated reloading of the capillaries with polymer matrix
by ABI Prism 3700 with 96 capillaries. This automated
DNA sequencer was successfully utilized in the sequencing
of the first human genome in 2003 taking into account 13-
years of efforts of the human genome project consortium,
and with an estimated cost of $2.7 billion. In the following
years, another landmark was achived by the DNA sequenc-
ing of the first small phage genome (5386 bases in length)
and sequencing of the human genome of upto∼3 billion
bases (Lander et al. 2001;V e n t e re ta l .2001). It is
remarkable that such progress has been made using
methods that are refinements of the basic ‘dideoxy’ method
introduced by Sanger in 1977.
Birth of HT-NGS
In 2000, Jonathan Rothberg founded 454 Life Sciences,
which further developed the first commercially available
NGS platform, the GS 20. The GS instrument was
414 J Appl Genetics (2011) 52:413–435introduced in 2005, developed by 454 Life Sciences
(www.454.com), as the first NGS system on the market.
The developed technique was successfully validated by
combining single-molecule emulsion PCR with pyrose-
quencing (shotgun sequencing procedure) of the entire 580
069 bp of the Mycoplasma genitalia genome at 96%
coverage and 99.96% accuracy in a single GS 20 run
(Margulies et al. 2005). In the following years, Roche
applied science acquired 454 Life sciences and extended
further the new version of the 454 instrument, i.e., the GS
FLX titanium. Sharing the same technological principle in
both GS 20 and GS FLX titanium, the flow cell is referred
to as a "picotiter well" plate, which is made from a fused
fiber-optic bundle. On a separate front, single-molecule
PCR in microcompartments consisting of water-in-oil
emulsions was also developed by Roche HT-NGS platform
(Tawfik and Griffiths 1998). In general, the principle of
pyrosequencing technique is based on the “sequencing by
synthesis”. It differs from Sanger sequencing because, it
depends on the detection of pyrophosphate release on
nucleotide incorporation, rather than chain termination with
dideoxynucleotides. The technique was developed by joint
efforts of Swedish group (the teams of M. Ronaghi, M.
Uhlen, and P. Nyren) in Stockholm (Ronaghi et al. 1996).
They first described a sequencing approach based on
chemiluminescent detection of pyrophosphate released
during polymerase-mediated deoxynucleoside triphosphate
(dNTP) incorporation (Nyren et al. 1993, Nyren 2007) and
the real-time DNA sequencing, utilizing this release of
pyrophosphate detection (Ronaghi et al. 1998). In pyrose-
quencing the DNA synthesis is performed within a complex
reaction that includes ATP sulfurylase and luciferase
enzymes and adenosine 5′ phosphosulfate and luciferin
substrates in such a way that, the pyrophosphate group
releases upon addition of a nucleotide, resulting in the
production of detectable light.
The HT-NGS techniques, which are new opportunities
and a great impact on mammalian genomics research were
selected as the methods of the year in 2007 (Schuster et al.
2008). However, the road to gain the acceptance of these
novel technologies was not an easy one. The first step of
the HT-NGS technique consisted in detecting the next
added fluorescently labeled base (reversible terminator) in
the growing DNA chain by means of a sensitive CCD
camera. This was performed on a large number of DNA
samples in parallel, attached either to a planar support or to
beads, on DNA chips, minimizing reaction volumes in a
miniaturized microsystem. In the next step the terminator
was converted into a standard nucleotide and the dye was
removed. This cycle and the process were repeated to
determine the next base in the sequence. The principle
described in this application is in part very quasi to that
used today in the so-called next-generation devices,
commercialized by Roche, Illumina-Solexa, ABI, Helicos
and other companies.
Principle of HT-NGS involves the DNA molecules,
which are sequenced in a massively parallel fashion in a
flow cell (Mardis 2008a, b; Metzker 2010). The sequenc-
ing is conducted in either a stepwise iterative process or in
a continuous real-time manner. By virtue of this highly
parallel process, each clonal template or single molecule is
“individually” sequenced and can be counted among the
total sequences generated. The high-throughput combina-
tion of qualitative and quantitative sequence information
generated has allowed advanced genome analyses that
were previously, either not technically possible or cost
prohibitive.
Second generation HT-NGS platforms
The second generation HT-NGS platforms can generate
about five hundred million bases of raw sequence (Roche)
to billions of bases in a single run (Illumina, SOLiD). These
novel methods rely on parallel, cyclic interrogation of
sequences from spatially separated clonal amplicons
(26 μm oil-aqueous emulsion bead [Roche: pyrosequencing
chemistry], 1 μm clonal bead [SOLiD: sequencing by
sequential ligation of oligonucleotide probes], clonal bridge
[Illumina: sequencing by reversible dye terminators]).
Currently, these (above mentioned) three leading second
generation HT-NGS platforms (Fig. 1) are commercially
available and the race for more additional platforms are
continuously on the horizon (for comprehensive reviews on
complete laboratory methods, technical aspacts of sample
preparation and resulting sequencing data analysis of
Roche, Illumina, SOLiD platforms, see: Mardis 2008a, b,
2009, 2010; Metzker 2010). In 2008, the US National
Human Genome Research Institute (NHGRI) has initiated
funding for a series of projects as part of its revolutionary
genome sequencing technologies program and aimed
toward its target goal of sequencing a human genome for
$1000 or less (http://www.genome.gov/27527585). Recent-
ly in December 2010, the NHGRI consortium has published
the most comprehensive map of human genetic variation
using next-generation DNA sequencing technologies to
systematically characterize the genetic differences among
179 individuals from four populations and 697 individuals
from seven populations in three pilot studies (Durbin et al.
2010). These pilot studies of the “1000 genomes project”
laid a critical foundation for studying human genetic
variation, and aimed to create a comprehensive, publicly
available map of genetic variation, that will ultimately
collect sequence from 2,500 people from multiple popula-
tions worldwide and underpin future genetics research
(http://www.genome.gov/27541917).
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In the previously discussed second generation HT-NGS
platforms, the principle was based on the emulsion PCR
amplification of DNA fragments, to make the light signal
strong enough for reliable base detection by the CCD
cameras. Although the PCR amplification has revolution-
ized DNA analysis, but in some instances it may introduce
base sequence errors or favor of certain sequences over
others, thus changing the relative frequency and abundance
of various DNA fragments that existed before amplifica-
tion. To overcome this, the ultimate miniaturization into the
nanoscale and the minimal use of biochemicals, would be
achievable if the sequence could be determined directly
from a single DNA molecule, without the need for PCR
amplification and its potential for distortion of abundance
levels. This sequencing from a single DNA molecule is
now called as the “third generation of HT-NGS technology”
(Schadt et al. 2010). The concept of sequencing-by-
synthesis without a prior amplification step, i.e., single-
molecule sequencing is currently pursued by a number of
companies and described below in Sects. 5.1 to 5.7.
Heliscope™ single molecule sequencer
One of the first techniques for sequencing from a single
DNA molecule was introduced by Braslavsky et al. 2003
and licensed by Helicos biosciences as the first commercial
single-molecule DNA sequencing system in 2007. The
principle of Heliscope sequencer relies on “true single
molecule sequencing” (tSMS) technology. The tSMS
technology begins with DNA library preparation through
DNA shearing and addition of poli-(A) tail to generated
DNA fragments (Ozsolak et al. 2010), followed by
hybridization of DNA fragments to the poli-(T) oligonu-
cleotides which are attached to the flow cell and simulta-
neously sequenced in parallel reactions. The sequencing
cycle consists of DNA extension with one, out of four
fluorescently labeled nucleotides, followed by nucleotide
detection with the Heliscope sequencer. The subsequent
chemical cleavage of fluorophores allows the next cycle of
DNA elongation to begin with another fluorescently labeled
nucleotide, which enables the determination of the DNA
sequence (Harris et al. 2008). The Heliscope sequencer is
capable of sequencing up to 28 Gb in a single sequencing
run and takes about 8 days. It can generate short reads with
a maximal length of 55 bases. In a recent development,
Helicos announced that it has developed a new generation
of “one-base-at-a-time” nucleotides which allow more
accurate homopolymer and direct RNA sequencing
(Ozsolak and Milos 2011a, b).
Single molecule real time (SMRT™) sequencer
The principle of SMRT sequencer relies on single molecule
real time sequencing by synthesis method provided on the
sequencing chip containing thousands of zero-mode wave-
guides (ZMWs). The sequencing reaction of a DNA
fragment is performed by a single DNA polymerase
molecule, which is attached to the bottom of each ZMW
so that each DNA polymerase resides at the detection zone
of ZMW (Fig. 2).
During the sequencing reaction, the DNA fragment is
elongated by DNA polymerase with dNTP’st h a ta r e
Fig. 1 Advanced technological
features of three leading
second generation HT-NGS
platforms
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fluorophore of different color) at the terminal phosphate
moiety. The DNA sequence is determined with CCD array
on the basis of fluorescence nucleotide detection, which is
performed before nucleotide incorporation, while the
labeled dNTP forms a cognate association with the DNA
template. The fluorescence pulse is stopped after phospho-
diester bond formation, which causes the release of a
fluorophore that diffuses out of ZMW. Subsequently, the
labeled nucleotide incorporation and detection allow us to
determine the DNA sequence (Levene et al. 2003; Eid et al.
2009). The SMRT sequencer was designed and is still being
developed by the Pacific Biosciences (www.pacific
biosciences.com). Although the SMRT instrument has
recently been available on the market, the company claims
that the SMRTanalyzer can be capable of obtaining 100 Gb
per hour with reads longer than 1000 in a single run.
Single molecule real time (RNAP) sequencer
A different single-molecule DNA sequencing approach, i.e.,
RNA polymerase (RNAP), has been proposed by (Greenleaf
and Block 2006) in which the RNAP is attached to one
polystyrene bead, whilst the distal end of a DNA fragment
is attached to another bead. Each bead is placed in an
optical trap and the pair of optical traps levitated the beads.
The RNAP interacts with the DNA fragment and the
transcriptional motion of RNAP along the template, changes
the length of the DNA between the two beads. This leads to
displacement of the two beads that can be registered with
precision in the Angstrom range, resulting in single-base
resolution on a single DNA molecule. By aligning four
displacement records, each with a lower concentration of
one of the four nucleotides, in a role analogous to the
primers used in Sanger sequencing and for calibration using
the known sequences flanking to the unknown sequenced
fragment, it is possible to deduce the sequence information.
The technique demonstrates that the movement of a nucleic
acid enzyme and the very sensitive optical trap method,
which may allow extraction of sequence information
directly from a single DNA molecule.
Nanopore DNA sequencer
In contrary to all DNA sequencers mentioned above,
sequencing a DNA molecule with the Nanopore DNA
sequencer is free of nucleotide labeling and detection. This
technique was developed from studies on translocation of
DNA through various artificial nanopores. The DNA
sequencing with Nanopore instrument relies on the con-
verting of electrical signal of nucleotides by passing
through a nanopore which is an α-hemolysin pore
covalently attached with cyclodextrin molecule – the
binding site for nucleotides. The principle of this technique
is based on the modulation of the ionic current through the
pore as a DNA molecule traverses it, revealing character-
istics and parameters (diameter, length and conformation)
of the molecule (Fig. 2). During the sequencing process the
ionic current that passes through the nanopore is blocked by
the nucleotide, i.e., the previously cleaved by exonuclease
from a DNA strand that interacts with cyclodextrin. The
time period of current block is characteristic for each base
Fig. 2 Advanced technological
features of four leading third
generation HT-NGS platforms
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al. 2006; Rusk 2009). However, further improvements and
modifications in the technique, for example, increasing the
number of parameters measured during the translocation of
the DNA enabling single-base resolution, could lead to a
rapid nanopore-based DNA sequencing technique.
Real time single molecule DNA sequencer platforms
developed by VisiGen Biotechnologies
The VisiGen biotechnologies (www.visigenbio.com) intro-
duced a specially engineered DNA polymerase, which
acting as a ‘real-time sensor’ for modified nucleotides with
a donor fluorescent dye and incorporated close to the active
site involved in selection of the nucleotides during
synthesis (Fig. 2). All four nucleotides to be integrated
were modified, each with a different acceptor dye. During
the synthesis, when the correct nucleotide is found, it
selected and entered into the active site of the enzyme, and
the donor dye label in the polymerase came into close
proximity with the acceptor dye on the nucleotides and
energy was transferred from donor to acceptor dye giving
rise to a fluorescent resonant energy transfer (FRET) light
signal (Selvin 2000). The frequency of this signal varied
depending on the label incorporated in the nucleotides, so
that by recording frequencies of emitted FRET signals was
possible to determine base sequences, at the speed at which
the polymerase can integrate the nucleotides during the
synthesis process (usually a few hundred per second). The
acceptor fluorophore is removed during nucleotide incor-
poration, which ensures that there are no DNA modifica-
tions that might slow down the polymerase during
synthesis. The company is currently working on its first
version of the instrument, which can generate around 4 Gb
of data per day. The single-molecule approach requires no
cloning and no amplification, which eliminates a large part
of the cost, relative to current technologies. In addition,
read lengths for the instrument are expected to be around
1 kb, longer than any current platform.
Multiplex polony technology
Run by the privately-funded personal genome project
(PGP) and lead by Prof. G Church’s research group
(www.personalgenomes.org), has developed and introduced
the multiplex polony technology (Mitra et al. 2003;
Shendure et al. 2005). In this technique, several hundred
sequencing templates are deposited onto thin agarose layers
and sequences are determined in parallel. This metod
presents increase of several orders of magnitudes in the
number of samples which can be analyzed simultaneously.
It has the advantage, in terms of large reduction of the
reaction volumes, requiring smaller amounts of reagents
and the resulting at a lower cost. The designed instrument,
i.e., Danaher Motion Polonator model G.007, is capable of
10 to 35 Gbp per module per 2.5 day run. Instrument can
couple with 200 of these modules to collect 100 diploid
genomes at 30X coverage in 5 days, with the remaining
5 days used for repeating any weak runs to assure 98%
coverage at 1E-5 accuracy. With the significant reduced
volume of reagents, the cost per unit volume is lower about
10-fold and the company hopes to meet the goal of $1000
per genome soon.
The Ion Torrent sequencing technology
In a recent advancement, the first PostLight
TM sequencing
technology (Ion Torrent) has been introduced (http://www.
iontorrent.com/). This technology creates a direct connec-
tion between the chemical and the digital information,
enabling fast, simple, massively scalable sequencing. It
utilizes the simple nucleic acid Watson’s chemistry to
incredibly powerful, proprietary of semiconductor technol-
ogy -The Moore’s law (Moore 1965). The principle of Ion
Torrent semiconductor technology is based on a well-
characterized biochemical process, in which a nucleotide
is incorporated into a strand of DNA by a polymerase,
resulting in a release of hydrogen ion as a byproduct
(Fig. 2). The technological device uses a high-density array
of micro-machined wells to perform this biochemical
process in a massively parallel way with each well holding
a different DNA template. Beneath the wells is an ion-
sensitive layer and beneath that a proprietary Ion sensor.
The massive parallel sequencing at Ion Personal Genome
Machine (PGM™) sequencer works on the basis of “base”
principle. For example, if nucleotide A is added to a DNA
template and it is incorporated into a strand of DNA and
then a hydrogen ion will be released. The charge from that
ion will change the pH of the solution and can be detected
directly by the ion sensor without scanning, cameras and
light. In this way, the PGM™ sequencer sequentially floods
the chip with one nucleotide after another. The designed
PGM™ system enables to perform wide range of sequenc-
ing application such as, multiplexing amplicons, tran-
scriptome, small RNA, and ChIP-Seq. paired-end
sequencing and methylation.
In terms of issues related to genomics data quality and
analysis, a substantial $10 million funding has been offered
by the Archon Genomics X PRIZE (AGXP), in order to
generate rapid, accurate and complete human DNA
sequences to global research community (editorial discus-
sion: Toward a medical grade human genome sequence. Nat
Genet. 2011 Mar, 43 [3]: 173). Because so many genome
researchers have a stake, AGXP offers to help with a
process of community consultation to help evolve fair and
efficient methods to validate contestant genome data at high
418 J Appl Genetics (2011) 52:413–435degrees of accuracy and completeness (Kedes et al. 2011).
Since the launch of AGXP in 2006, there have been
important advances in validation protocols of DNA
sequencing technologies both in terms of speed and
reduction in costs (Sutton et al. 2011). However, no current
human genome sequence is fully complete, fully accurate or
certain to contain all rearrangements or information of
chromosome phasing (haplotype). Highly repetitive and
other genome-wide regions remain difficult to sequence but
are likely to be critical in defining heritable features. Hence
the ideals of the X Prize remain as critical for the future of
human genetics and genetic medicine as ever.
Comparison of second and third HT-NGS platforms
Unlike the second HT-NGS technologies, that rely on PCR
to grow clusters of a given DNA template, attaching the
clusters of DNA templates to a solid surface that is
subsequently imaged as the clusters are sequenced by
synthesis in a phased approach, the third HT-NGS
technologies interrogate single molecules of DNA in a
such a way that no synchronization (a limitation of second
HT-NGS) is required (Whiteford et al. 2009), thereby
overcoming issues related to the biases introduced by PCR
amplification and dephasing. Furthermore, third HT-NGS
technologies have the potential to exploit more fully, the
high catalytic rates and high processivity of DNA
polymerase, or avoid any biology or chemistry altogether
to radically increase read length (from tens of bases, to
tens of thousands of bases per read) and time to result
(from days, to hours, or minutes). Besides this, the third
HT-NGS technologies may offer the following advantages
over second HT-NGS technologies: i) higher throughput,
ii) faster turnaround time (e.g., sequencing metazoan
genomes at high fold coverage in minutes), iii) longer
read lengths to enhance de novo assembly and enable
direct detection of haplotypes and even whole chromo-
some phasing, iv) higher consensus accuracy to enable
rare variant detection, v) small amounts of starting
material (theoretically only a single molecule may be
required for sequencing), and vi) low cost, where
sequencing the human genome at high fold coverage for
less than $1000 is now a reasonable goal for the
community.
In the past six years, an influx of plenty of original as
well as comprehensive review papers related to both second
and third generation HT-NGS platforms have been pub-
lished. Thereby, the comparison of second HT-NGS plat-
forms (Roche/454, SOLiD, and Illumina) and third HT-
NGS platforms (Helicos and Pacific Biosciences etc.) are
summarized in Table 1, illustrating the similarities and
differences in these technologies, according to several
metrics. For examples, in terms of technological features,
both platforms work sequencing by synthesis, however,
Second HT-NGS platform deals with washing and scan of
many copies of the DNA molecules in comparison to direct
physical inspection of the DNA molecule and its resolution
in real time (i.e., no protracted cycles of hybridization or
successive enzymatic steps) in third HT-NGS platforms.
Among other dissimarities are the RNA sequencing,
where, second HT-NGS platform only performed the
cDNA sequencing whereas direct RNA sequencing in
case of third HT-NGS platforms. Regarding data analysis,
both platforms have complexity because of large data
volume. In second HT-NGS platforms the mojor chal-
lenges are the short reads which can be complicated in
genome assembly and alignment algorithms, whereas new
signal processing challenges are still prominent in the
third HT-NGS platforms.
With the progressive advent of HT-NGS technologies,
DNA sequencing costs have been drastically reduced
(Table 1). Now, it is feasible to sequence hundreds or even
thousands of genes for a single individual with a suspected
genetic disease or complex disease predisposition. Along
with the benefits offered by these technologies, there are a
number of challenges that must be addressed before wide-
scale sequencing becomes accepted in genome research
practices. Molecular diagnosticians will need to become
comfortable with, and gain confidence with, these new
platforms, which are based on radically different technol-
ogies compared to the standard DNA sequencers in routine
diagnostic today. Since 2001, when the technology that
sequenced the human genome on the basis of capillary
electrophoresis of individual fluorescently labeled Sanger
sequencing method, the advent of next-generation sequenc-
ing platforms have dramatically increased the speed at
which DNA sequence can be acquired, while reducing the
costs by several orders of magnitude compared to their
predecessors (Fig. 3). This is because of the basic
mechanisms for data generation had changed radically,
producing far more sequence reads per instrument run and
at a significantly lower expense. Figure 3 illustrates how
the resulting HT-NGS information has both enhanced our
knowledge and expanded the impact of the genome on
biomedical research (Mardis 2011).
These next-generation platforms generate shorter reads
with lower quality, when compared to the Sanger platform.
The reduction in read length and quality necessitated the
development of bioinformatics tools to assist in either the
mapping of these shorter reads to reference sequences or de
novo assembly. The development of these new techniques
aims toward meeting the demand for sequence information
in various fields of research, such as study of genomics and
evolution, forensics, epidemiology and diagnostics and
applied therapeutics.
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420 J Appl Genetics (2011) 52:413–435Applications and advances of sequencing technologies
on human genome research
The landmark of sequencing of human genome was accom-
plished by two groups, i.e., the publicly funded Human
Genome Group (HGP) and Celera Groups. Both groups
utilized different strategies. The HGP group produced a
working draft of the human genome by a map-based strategy,
while Celera, to sequence the human genome by the whole-
genome shotgun(WGS) approach (Fig.4). The availability of
sequence material obtained through different approaches
greatly facilitated the ability of the entire scientific commu-
nity to interpret the data. The strategy of HGP originally
established by the publicly funded effort and was based on
the localizing bacterial artificial chromosomes (BACs)
containing large fragments of human DNA within the
framework of a landmark-based physical map. Ideally,
sequencing would have been done on a clone-by-clone basis,
with clones selected from the minimum BAC tiling path. The
key to the HGP's strategy was the subsequent 'mapping' step
in which the BACs were each positioned on the genome's
chromosomes by looking for distinctive marker sequences,
called sequence tagged sites (STSs), whose location had
already been pinpointed. In this way, the BACs provided a
high-resolution map of the entire genome (Fig. 4). The
working draft, although containing some gaps and ambigu-
ities in order, is extremely useful in such efforts as identifying
disease-associated genes. Simultaneously, the idealized strat-
egy of Celera was to avoid the up-front mapping phase by
subcloning random fragments of the human genome directly.
Sequencing of both ends of fragments in libraries of different
sizes facilitated ordering. While saving time and effort at the
beginning, the Celera approach made the assembly process
much more dependent on algorithms and computer time. In
their efforts to reach their goals, the idealized strategies
evolved into hybrids in which the HGP selected more clones
arbitrarily and Celera made use of BAC maps and sequence
generated by the HGP (Fig. 4).
Since the introduction of HT-NGS platform in 2005, the
production of large numbers of low-cost reads made the
Fig. 3 Changes in instrument capacity over the past decade, and the
timing of major sequencing projects (Figure updated from Madris,
2011). On top: increasing scale of data output per run plotted on a
logarithmic scale. At middle: timeline representing major milestones
in massively parallel sequencing platform introduction and instrument
revisions. On bottom: the time lines of several projects, milestones and
publications citing different sequencing technologies
J Appl Genetics (2011) 52:413–435 421NGS platforms useful for many applications on human
genomes research particularly, the de novo genome se-
quencing, whole-genome resequencing or more targeted
sequencing, cataloguing the transcriptomes of cells tissues
and organisms (RNA–seq), genomic variation and mutation
detection, genome-wide profiling of epigenetic marks and
chromatin structure using methyl– seq, DNase–seq and
ChIP–seq (chromatin immunoprecipitation coupled to DNA
microarray) and personal genomics (Table 2).
De Novo, resequencing and targeted sequencing
In general, the HT-NGS platforms made de novo assembly
of most organisms including human, a lengthy and costly
endeavor. In humans, such an endeavor had already
commenced with the publication of several complete
genomes, for example: using the Roche 454 technology to
7.5x human genome coverage (Wheeler et al. 2008), human
genome sequences of Chinese (Wang et al. 2008), an
African (Pushkarev et al. 2009), and two Korean individ-
uals (Ahn et al. 2009; Kim et al. 2009), all were done using
the Illumina Genome Analyzer and sequenced around 20x
haploid genome coverage with the exception of the African
male’s genome which was also resequenced on ABI SOLiD
system (McKernan et al. 2009). More recently, James
Lupski’s genome was sequenced to 30x base coverage
using ABI’s SOLiD System (Lupski et al. 2010). Rese-
quencing of human genome was not limited to the second
generation platforms. Steven Quake’s genome, for example,
was sequenced to 90% genome coverage on Helicos’
single-molecule sequencing platform (Pushkarev et al.
2009). The whole genome genotyping approach on HT-
NGS effectively enables unlimited multiplexing and un-
constrained single nucleotide polymorphism (SNP) selec-
tion, for example typing of HLA genotypes in human (Lind
et al. 2010) and genome-wide fetal genotyping using non-
invasive HT-NGS of the mother's blood (Burgess 2011).
RNA sequencing
HT-NGS is also finding application in the study of small
RNAs. For example, a comprehensive study of miRNA in
acute myeloid leukaemia performed by HT-NGS identified
differentially expressed miRNAs binding sites for acute
myeloid leukaemia (Ramsingh et al. 2010). In recent
studies, several efficient procedures have been introduced
to perform RNA-Seq using the Illumina sequencing
platform (Buermans et al. 2010; Nagalakshmi et al. 2010)
including the technical issues (Marguerat and Bähler 2010),
Construction of complex miRNA repertoire database (Lee
et al. 2010), preparation the small RNA libraries and
analyses of the resultant sequence data for measuring
microRNA abundance (Morin et al. 2010), as well as
annotation and discovery of small RNAs from transcrip-
tomic data (Yang et al. 2011). RNA seq using Illumina and
454 technologies has also been found to be a powerful tool
Fig. 4 Two strategies for gener-
ating the first complete human
genome sequence: On right, the
Human Genome Project (HGP)
map-based strategy (Lander et
al. 2001) showing the localizing
bacterial artificial chromosomes
(BACs) containing large frag-
ments of human DNAwithin the
framework of a landmark-based
physical map. On left, the
Celera’s strategy (Venter et al.
2001) showing the whole
genome shotgun sequencing
approach
422 J Appl Genetics (2011) 52:413–435Table 2 An overviews of impact HT-NGS technology on human genome researches (Only year 2010 and first issues of 2011 literatures were
included)
Applications Description References
1. Whole genome
genotyping
Typing of Human leukocyte antigen (HLA) by HT-NGS: A three step
procedure of HLA typing was introduced. In first step, HLA-A, -B, -C,
-DRB1, and -DQB1 were amplified with long-range PCR. In second step,
amplicons were sequenced using the 454 GS-FLX platform. In third step,
sequencing data were analyzed with Assign-NG software.
Lind et al. 2010
HT-NGS in prenatal diagnosis tests: A comprehensive review on impact of
HT NGS on prenatal diagnosis tests.
Raymond et al. 2010
In utero disease screening: A new study demonstrates the feasibility of
genome-wide fetal genotyping using non-invasive next-generation se-
quencing of the mother's blood
Burgess 2011
2. De Novo assembling and
re-assembling of the
human genome.
Re-sequencing of genome by DNA pools: study proposed a novel statistical
approach, CRISP (Comprehensive Read analysis for Identification of SNPs
from Pooled sequencing] that is able to identify both rare and common
variants. The CRISP approach can detect 80-85% of SNPs identified using
individual sequencing while achieving a low false discovery rate (3-5%).
Bansal 2010
Re-sequencing of genome and HT-NGS platform: study evaluated the
comparative performance of the Illumina Genome Analyzer and Roche 454
GS FLX for the re-sequencing of 16 genes associated with hypertrophic
cardiomyopathy (HCM). Study concluded the feasibility of combining LR-
PCR with NGS platforms for targeted re-sequencing of HCM-associated
genes.
Dames et al. 2010
De novo assembling of the human genome: study proposed a novel method
for de novo assembly of human genomes from short read sequences.
Method successfully assembled N50 contig size of 7.4 and 5.9 kilobases
(kb) and scaffold of 446.3 and 61.9 kb of Asian and African human
genome.
Li et al. 2010a
Assembling of the human genome: A comprehensive review on recent
development of software packages in analyzing new generation sequencing
data.
Nagarajan and Pop 2010
HT-NGS in ancient genome research: study sequenced the complete
genome of a 4,000-year-old human with 20-fold coverage which providing
a fresh look at human population history.
Shapiro and Hofreiter 2010
Epigenetics DNA methylation and HT-NGS: study compared two different bisulfite
conversion whole methylome sequencing methods using NGS SOLiD platform.
Bormann et al. 2010
HT-N G Si ne p i g e n o m i c s : study presented the methylation detection reagents and
their application to microarray and sequencing platforms. Study also proposed
an international coordination to standardize methylome platforms and to create
a full repository of methylome maps from tissues and unique cell types.
Fouse et al. 2010
Profiling genome methylation patterns at single-base resolution: Study
provides new insights into the conservation and divergence of DNA
methylation in eukaryotes and their regulation of gene expression.
Bhaijee et al. 2011
Database for whole genome methylation maps at single-cytosine
resolution: NGS methylation database (NGSmethDB: http://bioinfo2.ugr.es/
NGSmethDB/gbrowse/) for human, mouse and Arabidopsis genome,
comprised of wide range of tissues including the differential tissue
methylation or the changes occurring along pathological conditions.
Hackenberg et al. 2011
ChIP-seq Study of gene expression regulation through HT-NGS: Study indentified
both coding and regulatory regions of PPARG gene-novel nucleotide
variations and haplotypes associated to human diseases by DNA-seq,
defining a PPARγ binding map by ChIP-Seq, and unraveling the wide and
intricate gene pathways regulated by PPARG by RNA-Seq.
Costa et al. 2010a
Advance statistical methods for Chip-seq mapping: Improved method to
predict the de novo motif discovery in the peak environments by
investigating the human growth-associated binding protein (GABPalpha)
based on ChIP-seq observations.
Jiao et al. 2010
Genome wide structural
variation detection in
human population
HT-NGS in 1000 genome project: Pilot study by whole-genome sequencing
of 179 individuals from four populations, to develop and compare different
strategies for genome-wide sequence variation using HT NGS platforms.
Durbin et al. 2010
Study of fine scale human population structural variation: to implicate in
population structure for the distribution and discovery of disease-causing
genetic variants in diverse human genomes, using HT-NGS sequencing data.
Henn et al. 2010
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Applications Description References
Detection of disease-causing mutations in patients with monogenic
inherited diseases: The Retinitis pigmentosa (RP): Study demonstrates that
next-generation sequencing is an effective approach for detecting novel, rare
mutations causing heterogeneous monogenic disorders such as RP. With the
addition of this technology, disease-causing mutations can now be identified
in 65% of autosomal dominant RP cases
Bowne et al. 2011
Detecting structural variations in the human genome using next
generation sequencing: A comprehensive review on application of HT-
NGS technology in identification of sequencing-based algorithms for
detection of structural variations of human genome.
Xi et al. 2010
Mutation detection and
carrier screening
"Functional genomic fingerprinting"( FGF) in mutation detection: Study
proposed a selective enrichment of functional genomic regions (the exome,
promoterome, or exon splice enhancers) approach (FGF) to HT-NGS, in
response to discovery of causal mutations for disease and drug response.
Senapathy et al. 2010
Target HT-NGS in disease mutation detection: Study identified a mutation
in a gene and have shown its association with autosomal-recessive
cerebellar ataxia, by combining SNP array-based linkage analysis and
targeted resequencing of relevant sequences in the linkage interval with the
use of next-generation sequencing technology.
Vermeer et al. 2010
Microarray-based target enrichment in HT-NGS: Study allowed the
parallel, large-scale analysis of complete genomic regions for multiple genes
of a disease pathway and for multiple samples simultaneously, thus provides
an efficient tool for comprehensive diagnostic screening of mutations.
Amstutz et al. 2011
Pre-conceptional carrier screening of 448 severe recessive childhood
diseases: An economic way of carrier screening by HT-NGS is possible and
available to the general population with severe recessive childhood disorders
Bell et al. 2011
Detection of inherited
disorders
Detection of monogenic inherited disorders: Study revealed the
identification of human monogenic disorders by sequencing of all exons in
the human genome (exome sequencing).
Kuhlenbäumer et al. 2011
Role of HT-NGS neurogenetics and psychiatric disorders: Comprehensive
review of impact of HT-NGS on last two decades on brain research
including large number of neurological and psychiatric disorders.
Zoghbi and Warren 2010
Impact of HT-NGS to understand the genetic causes of disorders of sex
development (DSD): a combined approach of comparative genomic
hybridization, sequencing by hybridization with HT-NGS was presented to
understand the genetic basis of human sexual determination and differen-
tiation.
Bashamboo et al. 2010
Complex human diseases HT-NGS in exploiting the complex disease traits: comprehensive review on
the experimental design considerations, data handling issues and required
analytical developments tools in mapping genetic traits using NGS.
Day-Williams and Zeggini
2010
Genome-wide association studies (GWAS) using HT-NGS: Systematically
identifying the genetic risks that lead or predispose to complex diseases by
HT-NGS.
Singleton et al. 2010
HT-NGS in clinical diagnosis: principles of sequencing library preparation,
sequencing chemistries, and NGS data analysis for targeted re-sequencing
of genes implicated in hypertrophic cardiomyopathy.
Voelkerding et al. 2010
HT-NGS in identifying the causal variants of human disease:A
comprehensive review on identification of causal variant typically involves
in the vicinity of disease-associated SNPs including protein coding,
regulatory, and structural sequences.
Kingsley 2011
Cancer research Analysis of HT-NGS data in cancer genomics: Introduction to set up of an
integrate database for multiple cancers and tumor genomes to understand a
coherent picture of the genetic basis of cancer.
Ding et al. 2010
ImpactofHT-NGS on surgical oncology: Fast growing HT-NGS technology
enables to identify the causal mutations responsible for driving cancer
initiation and metastasis and raises significant expectations for improving
oncologic outcomes.
Katsios et al. 2010
Understanding the cancer genomes through HT-NGS: icluding somatic
genome alterations, cancer biology, diagnosis and therapy through whole-
genome, whole-exome and whole-transcriptome HT-NGS approaches.
Meyerson et al. 2010
HT-NGS in cancer researches: A Comprehensive review on HT-NGS
applications to cancer genome, particularly, the glioblastoma multiforme
Pfeifer and Hainaut 2011
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that identified the gene encoding isocitrate dehydrogenase 1 (IDH1), as
target for cancer-driving mutations.
Understanding of the potential actions of SOX2 in carcinogenesis:
identification of 4883 SOX2 binding regions in the GBM cancer genome
using the HT-NGS Chip-seq technology
Fang et al. 2011
RNA sequencing MicroRNA expressing profiling by HT-NGS: study proposed an alternative
improved method to generate high quality miRNA sequencing libraries for
the Illumina genome analyzer.
Buermans et al. 2010
RNA-seq in HT-NGS: A comprehensive review on RNA-Seq for tran-
scriptome studies supported by HT-NGS platforms. Study also addressed
how to determine accurately the expression levels of specific genes,
differential splicing, allele-specific expression of transcripts and many
biological-related issues utilized in RNA-Seq experiments.
Costa et al. 2010b
Classification of Small non-coding RNAs (ncRNAs) using HT-NGS: Study
demonstrated a scoring system called alignment of pattern matrices score
(ALPS) that only uses the relative positions and lengths of reads of NGS
data, to classify ncRNAs (http://www.bio.ifi.lmu.de/ALPS).
Erhard and Zimmer 2010
Construction of complex miRNA repertoire database: A comprehensive
survey of miRNA sequence variations from human and mouse samples
using next generation sequencing platforms. Study device a method to
construct a database to determine the most abundant sequence and the
degree of heterogeneity for each individual miRNA species that catalogs the
entire repertoire of miRNA sequences (http://galas.systemsbiology.net/cgi-
bin/isomir/find.pl)
Lee et al. 2010
Analysis of miRNA profiling in HT-NGS: introduction of an efficient
procedure to prepare the small RNA libraries for Illumina sequencing and
analyses of the resultant sequence data for measuring microRNA
abundance.
Morin et al. 2010
RNA-seq and HT-NGS: study introduced an efficient procedure for
performing RNA-Seq using the Illumina sequencing platform
Nagalakshmi et al. 2010
RNA-seq and HT-NGS: a comprehensive review on RNA-Seq including the
technical issues accompanying RNA-seq data generation and analysis.
Marguerat and Bähler 2010
HT-NGS in miRNA: First complete characterization of the "miRNAome" in
a primary human cancer: study identified genetic variants of miRNA genes,
and screen for alterations in miRNA binding sites in a patient with acute
myeloid leukemia.
Ramsingh et al. 2010
HT-NGS in functional genomics: A comprehensive review on contribution
NGS-based technologies in functional genomics research with a special
focus on gene regulation by transcription factor binding sites.
Werner 2010
Annotation and mining of HT-NGS data: study proposed a novel database
(The deepBase) to facilitate the comprehensive annotation and discovery of
small RNAs from transcriptomic data.
Yang et al. 2011
Library preparation, paired
ends and genomic
captures for NGS
platforms
Library preparationin HT-NGS: study presented a robust and cost-effective
preprocessing method for DNA sample library construction using a unique
6 bp DNA barcode, which allowed multiplex sample processing and
sequencing of 32 libraries in a single run using Applied Biosystems SOLiD
sequencer.
Farias-Hesson et al. 2010
Paired-end sequencing in HT-NGS: study proposed a NovelSeq pipeline
(http://compbio.cs.sfu.ca/strvar.htm) to detect and characterize multiple
types of genetic variation (SNPs, structural variation, etc.).
Hajirasouliha et al. 2010
Library preparations for tissue specific expression profiling in HT-NGS:
study compared NGS with two alternative technologies, cap analysis of
gene expression (CAGE) and serial analysis of gene expression (SAGE) and
identified 196 novel regulatory regions with preferential use in proliferating
or differentiated cells. These CAGE and SAGE libraries provides consistent
expression levels and can enrich current genome annotations with tissue-
specific promoters and alternative 3'-UTR usage.
Hestand et al. 2010
Genomic capture in HT-NGS: study developed an accurate, thorough, and
cost-effective identification of inherited mutations for breast and ovarian
cancer, through a genomic assay to capture, sequence, and detect all
mutations in 21 genes, including BRCA1 and BRCA2, with inherited
mutations that predispose to breast or ovarian cancer.
Walsh et al. 2010
J Appl Genetics (2011) 52:413–435 425for detecting novel gene fusions in cancer cell lines and
tissues (Maher et al. 2009). Understanding the transcrip-
tome is essential for interpreting the functional elements of
the genome and revealing the molecular constituents of
cells and tissues, and also for understanding development
and disease. The specific aims of transcriptomics are: (1) to
catalog all transcripts in a context of cell types for a species,
including mRNAs, non-coding RNAs and small RNAs, (2)
to determine the transcriptional structure of genes, in terms
of their start sites, 5’- and 3’-ends, splicing patterns and
other post-transcriptional modifications and (3) to quantify
the expression levels of each transcript during development
or under different physiologic and pathological conditions.
With the availability of faster and cheaper HT-NGS
platforms, more transcriptomic analyses are performed
using a recently-developed deep sequencing approach
(Wang et al. 2009). The short reads produced by HT-
NGS technologies, particularly Illumina and SOLiD, are
arguably suitable for gene expression profiling. RNA-Seq
has been used to accurately monitor gene expression of
specific genes to determine the differential splicing, allele-
specific expression of transcripts and many biological-
related issues utilized in RNA-Seq experiments (Costa et
al. 2010b).
Epigenetics
The HT-NGS technologies offer the potential to substan-
tially accelerate epigenomic research (the study of heritable
gene regulation that does not involve the DNA sequence
itself but its modifications and higher-order structures),
including posttranslational modifications of histones, the
interaction between transcription factors and their direct
targets, nucleosome positioning on a genome-wide scale
and the characterization of DNA methylation patterns
(Bormann et al. 2010; Fouse et al. 2010; Bhaijee et al.
2011). Histone modification and methylation of DNA are
two important epigenetic mechanisms that regulate the
transcriptional status of genes. Using ChIP-Seq (chromatin
immunoprecipitation and direct sequencing) technology,
post-translational modifications of histones and the location
of transcription factors can be studied at the whole-genome
level (Neff and Armstrong 2009), whereas methylated DNA
immunoprecipitation (meDIP) and bisulphite protocols can
be used to study the methylation of DNA itself (Popp et al.
2010). For example, using ChIP-seq on HT-NGS platform,
the binding sites for a transcription factor (TF) and the
human growth-associated binding protein (GABP alpha)
were directly sequenced instead of being hybridized on a
chip-array and unraveling the wide and intricate gene
pathways regulated by PPARG gene (Costa et al. 2010a)
and predicted the de novo motif discovery (Jiao et al.
2010). This ChIP-Seq on HT-NGS platform allows now
researchers to improve both quantity and quality of
produced data. Among other prevalent high-throughput
approaches, protein-DNA interactions have been studied by
the combination of chromatin immunoprecipitation with
DNA microarray (ChIP-chip). Contrarily, ChIP-seq tech-
nique inherits two advantages from the HT-NGs platforms,
firstly, it is not limited by the microarray content and
secondly, it does not depend on the efficiency of probe
hybridization. The ChIP-seq approach was recently used to
identify binding sites of two transcription factors, STAT1
and NRSF in human cells (Robertson et al. 2007;
Euskirchen et al. 2007). Both studies compared their
findings with those generated by ChIP-chip, demonstrating
that ChIP-seq had better resolution and required fewer
replicates.
Table 2 (continued)
Applications Description References
Sequencing of
mitochondrial genome
Annotation of mitochondrial genome HT-NGS: study proposed a high-
throughput sequencing and bioinformatics pipeline for mt genomics, which
have implications for the annotation and analysis of other organelles (e.g.
plastid or apicoplast genomes) and virus genomes as well as long,
contiguous regions in nuclear genomes.
Jex et al. 2010
HT NGS in mitochondrial genome: Study developed and proposed a
pipeline for sequencing and de novo assembly of multiple mitochondrial
genomes without the costs of indexing.
McComish et al. 2010
Sequencing of complete four F-type mitochondrial genomes (15 761 bp)
from the European freshwater bivalve Unio pictorum (Unionidae):
Comparison of mitochondrial genomes revealed very low nucleotide
diversity within the species which may have the potential importance for
environmental management policies.
Soroka and Burzynski 2010
Personal genomics Exploring the personal human genome by total integrated archive of
short-read and array (TIARA): Set up of improved database for accurate
detection of personal genomic variations, such as SNPs, short indels and
structural variants (SVs).
Hong et al. 2011
426 J Appl Genetics (2011) 52:413–435Genomic variation and mutation detection
NGS promises to facilitate the genome-wide human
population structural variation studies (Xi et al. 2010; Henn
et al. 2010) by uncovering all of the common and rare
genetic variation in human populations (Bowne et al. 2011).
Indeed, the “1000 Genomes Project” has made great
progress to date toward this goal (Durbin et al. 2010). With
a comprehensive genetic map of all human variation
produced by NGS, researchers will be able to perform
more detailed experiments to detect genetic variation
underlying the response to medicines. HT-NGS patforms
have also found application in high throughput mutation
detection and carrier screening using a method called
functional genomic fingerprinting (FGF). The method
implies a selective enrichment of functional genomic
regions (the exome, promoterome, or exon splice
enhancers) approach in response to discovery of causal
mutations for disease and drug response (Senapathy et al.
2010). The target enrichment based on microarray also
allowed the parallel, large-scale analysis of complete
genomic regions for multiple genes of a disease pathway,
and for multiple samples simultaneously, thus providing an
efficient tool for comprehensive diagnostic screening of
mutations (Amstutz et al. 2011). The carrier screening by
HT-NGS is also feasible to the general population with
severe recessive childhood disorders (Bell et al. 2011) and
in mutation detection associated with autosomal-recessive
cerebellar ataxia, by combining SNP array-based linkage
analysis and targeted resequencing of relevant sequences in
the linkage interval (Vermeer et al. 2010).
Cancer research and biomarkers
HT- NGS technological advances are also driving the
development of novel diagnostic and therapeutic
approaches to the treatment of cancer (Meyerson et al.
2010), as researchers re-sequence the tumor and normal
genomes comparision from specific types of cancer (Pfeifer
and Hainaut 2011). In cancer genome, it enables rapid
identification of patient-specific rearrangements in solid
tumours (Ding et al. 2010, McBride et al. 2010). A further
interesting application of the technology is ‘personalized’
biomarkers, which has recently been developed to detect
the presence of tumour-specific genomic rearrangements in
plasma samples from patients to generate a tumour-specific
biomarker. Genomic rearrangements were identified specif-
ic to the tumour, which were not present in the patient's
normal somatic tissue. Digital PCR assays were then
designed across rearrangement breakpoints to provide a
sensitive tumour-specific biomarker which was successfully
used to monitor residual disease following treatment (Leary
et al. 2010). Furthermore, HT-NGS technology also enables
to identify the causal mutations responsible for driving
cancer initiation and metastasis and raises significant
expectations for improving oncologic outcomes (Katsios
et al. 2010) and identification of 4883 SOX2 binding
regions in the Glioblastoma (GBM) cancer genome (Fang et
al. 2011). Small RNAs could provide a further application
of NGS in biomarker discovery (Lee et al. 2010). Micro-
RNAs (miRNAs) are implicated in the control of protein
translation and are present in blood plasma. NGS could be
used to assay tissues or blood plasma to generate whole-
genome miRNA profiles, which could then be mined for
biomarker signatures.
Applications and advances of sequencing technologies
on animal genome research
Discussion pertaining to the economically important farm
animals in context to impact of HT-NGS technology is also
a scope of this publication. The updated assembled animal
genome server is available for the following species: cat
(Felis catus), chicken (Gallus gallus), cow (Bos taurus),
dog (Canis lupus familiaris), horse (Equus caballus) and
pig (Sus scrofa)( http://www.ensembl.org/info/about/
species.html). Additionally, the preview of genome assem-
ble is also available for the sheep (Ovis aries)( http://pre.
ensembl.org/Ovis_aries/Info/Index) and turkey (Meleagris
gallopavo) genome (http://pre.ensembl.org/Meleagris_
gallopavo/Info/Index). The important characteristics fea-
tures of these assembled animal genomes are summarized
in Table 3.
The first initiative toward animal genome sequencing
started, just after the human genome sequencing conducted
in 2001 (Lander et al. 2001; Venter et al. 2001) to advocate
public funding for animal genomics research from several
universities, private industries, producer groups and Animal
Genome Research (AGR) scientific group. At the begin-
ning, AGR under the National Academy of Sciences (NAS)
organized a public workshop on “exploring horizons for
domestic animal genomics” (Pool and Waddell 2002). The
workshop objective was to identify research goals, public
and private fundings to generate high-coverage, draft
genome sequences of the major domestic animal species,
i.e., cattle, pig, horse, sheep, chicken, dog and cat. In the
initial phase, two “white papers” were released in support
for sequencing and assembling the cattle genome (Gibbs et
al. 2002) and pig genome (Rohrer et al. 2002). Since then,
considerable progress has been achieved toward the whole
genome sequence of domestic animals. In 2006, latest
progress and updates on bovine (Womack 2006), porcine
(Mote and Rothschild 2006), sheep (Cockett 2006), horse
(Chowdhary and Raudsepp 2006), chicken (Burt 2006),
canine (Galibert and André 2006) and feline (Murphy
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428 J Appl Genetics (2011) 52:413–4352006) genome sequencing were comprehensively reviewed
and published. For the recent progress and development in
domestic animals genome sequencing and assembling, a
series of publications and studies were published(Table 3),
for bovine (Liu 2009; Elsik et al. 2009; Zimin et al. 2009),
porcine (Wiedmann et al. 2008; Amaral et al. 2009; Ramos
et al. 2009; Isom et al. 2010; Leifer et al. 2010), sheep
(Archibald et al. 2010), horse (Bright et al. 2009; Coleman
et al. 2010), chicken (Dalloul et al. 2010, Marklund and
Carlborg 2010).
In the past, animal genome researches have effectively
adapted to traditional breeding program objectives, i.e.,
genetic improvement of the livestock through marker
assisted selection (MAS) and gene assisted selection
(GAS) program. The MAS programs were successfully
implemented during mid 1990s through global animal
genome scan procedures and quantitative trait loci (QTL)
mapping (for example cattle: Georges et al. 1995 and pig:
Andersson et al. 1994). The GAS program was well
implemented to animal genomes with identification of
candidate genes and detection of casual quantitative trait
nucleotides (QTN) discoveries (for example cattle: Grisart
et al. 2001 and pig: Van Laere et al. 2003). In the past five
years, HT-NGS technologies emerged as a potential
research tool for the development of animal genomes
research. Now, in this genomics era, the livestock research-
ers are working on effective implementation of genomics
breeding for selection (GBS) in their traditional breeding
program toward genetic improvement of economic traits.
In contrast to human, the progress to adopt the HT-NGS
technologies in animal genome is at a lower pace,
predominantly because of high cost and limited publically
funded projects. However, continuous advancement of HT-
NGS through the fast track human research and feasibility
of genome sequencing for 1000 $, the pace will be geared
up faster in the near future. The overall review on impact of
current HT-NGS in animal genome is presented in Table 4.
Concluding summary and future prospective
In the fast growing HT-NGS technologies, the main
challenge is to cope with the analysis of vast production
of sequencing database through advanced bioinformatics
tools. As the year 2011 has been marked as the 10th
anniversary of the first human genome sequencing, nucleic
acid research (NAR) has recently published its 18th annual
database issue (Volume 39, supplement 1 January 2011:
http://nar.oxfordjournals.org/content/39/suppl_1)t od e d i -
cate 10 years achievements in genome sequencing and its
future challenges ahead. The published issues comprised of
96 new online databases covering a variety of molecular
biology data and 83 data resources that have previously
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Domestic animals Description References
Cow (Bos Taurus) Construction of high-density bovine SNP arrays: paper addressed an economical, efficient,
single step method for SNP discovery, validation and characterization that utilizes the HT-NGS
sequencing generated reduced representation libraries (RRLs) from specified target popula-
tions. The developed strategy allowed simultaneous de novo assembling of high-quality SNPs
and the population characterization of allele frequencies may be applied to any species with at
least a partially sequenced genome
Van Tassell et al. 2008
Whole genome sequencing of Fleckvieh breed: study generated 24 gigabases of sequence,
mainly using 36-bp paired-end reads, resulting in an average 7.4-fold sequence depth and
identified 2.44 million SNPs, 82% of which were previously unknown, and 115,000 small
indels.
Eck et al. 2009
Assembling of Bos taurus genome: systematic three steps of bovine genome assembling were
described. It is accomplished by first assembling of BACs in combination with the individual
overlapping WGS reads, followed by assembly of only the WGS sequences. Secondly, both
assemblies were combined to create a more complete genome representation that retained the
high quality BAC-based local assembly information with gaps between BACs filled in with
the WGS-only assembly, and finally the entire assembly was placed on chromosomes using the
available map information.
Liu et al. 2009
Development of diagnostics test: Prospective of HT-NGS technology which may lead to
develop specific and sensitive diagnostics test for M. bovis infection and eventually in
eradication of tuberculosis from cattle populations were discussed.
MacHugh et al. 2009
Assembling of Bos taurus genome: upgrading of existing Bos taurus genome with excellent
large-scale contiguity in which a large majority (approximately 91%) of the genome has been
placed onto all 30 Bos taurus chromosomes and re-constructed a new cow-human synteny
map and also identified for the first time a portion of the Bos taurus Y chromosome.
Zimin et al. 2009
Identification of the genetic disorder: using combined an array-based sequence capture and
massively parallel sequencing approach causative mutation of Bovine Arachnomelia was
identified in bovine sulfite oxidase (SUOX) gene.
Drögemüller et al. 2010
Within the host dissecting the FMD virus population: study compared the viral populations
within two bovine epithelial samples (foot lesions) from a single animal with the inoculums
used to initiate experimental infection using Genome Analyzer HT-NGS platform (Illumina).
Wright et al. 2011
Water buffalo
(Bubalus bubalis)
A comprehensive review: on water buffalo genome: apart from genomic anatomy, mapping,
prospects of whole genome sequencing and HT-NGS platforms were discussed.
Michelizzi et al 2010
Application of Illumina BovineSNP50 BeadChip on water buffalo genome: Study effectively
and successfully utilized the Illumina BovineSNP50 BeadChip on water buffalo genome and
54,001 fully scored and 6,711 partially scored SNPs. Study provides a solid foundation to
further characterize the SNP evolutionary process, thus improving understanding of within-
and between-species biodiversity, phylogenetics and adaption to environmental changes.
Michelizzi et al. 2011
Aurochs
(Bos primigenius)
Genome sequencing of ancient DNA: Study performed the aurochs (Bos primigenius) genome
(289.9 MB) and mitochondrial sequencing using both Sanger and Illumina HT-NGS platforms.
Comparative genome analysis with bos taurus genome revealed high-confidence calls with no
discrepancies.
Edwards et al. 2010
Pig (Sus scrofa
domesticus)
Porcine SNP discovery: using a combined reduced representation and HT-NGS approach,
approximately 5 million sequence reads were collected and assembled into contigs having an
overall observed depth of 7.65-fold coverage and 12.6 fold porcine SNP coverages. Study
identified large number of SNP (115,572) with greater confidence and relatively high minor
allele frequencies (MAF) in 47,830 contigs.
Wiedmann et al. 2008
Porcine SNP discovery using the Illumina 1 G Genome Analyzer: identification large
numbers of porcine SNPs (17,489) by creating strict rules for sequence selection, which
simultaneously decreases sequence ambiguity, i.e., a higher sequence quality (SQ) threshold
leads to more reliable identification of SNPs.
Amaral et al. 2009
Comparative analysis of four pig breeds by HT-NGS: study identified and assembled de novo
over 372 k porcine SNPs and more than 549 K SNPs were used to design the Illumina Porcine
SNP60K iSelect Beadchip.
Ramos et al. 2009
Prenatal transcriptomic profiling by HT-NGS: RNA sequencing of trophectoderm (TE) and
embryonic disc (ED) of a single day 12 porcine embryo was performed using the Illumina
NGS platform. Study confirms the presence of abundance of TE and ED specific genes in HT-
NGS generated data.
Isom et al. 2010
Genome sequencing of classical swine fever (CSF) virus: five different strains of CSFV
subgroup 2.3 were completely sequenced using these newly developed NGS protocols.
Leifer et al. 2010
Poultry
(Gallus gallus)
Identification of SNPs using re-sequencing of limited coverage (~5X) chicken genome:O n
average, ~3.7 SNPs/kb were detected by re-sequencing of pooled DNA on 60 K SNP chip,
with about 5% lower density on microchromosomes than on macrochromosomes.
Marklund and Carlborg
2010
430 J Appl Genetics (2011) 52:413–435been published in NAR or other journals, in total the
database collection now includes 1330 data sources.
The availability of ultra-deep sequencing of genomic
DNA will transform the medical (in analysis of the causes
of disease, development of new drugs and diagnostics) and
veterinary (genetic improvement of animal health and
productivity) fields in the near future. Further, it may
become a promising tool in the analysis of chromatin
immunoprecipitation coupled to DNA microarray (ChIP-
chip) or sequencing (ChIP-seq), RNA sequencing (RNA-
seq), whole genome genotyping, de novo assembling and
re-assembling of genome, genome wide structural variation,
mutation detection and carrier screening, detection of
inherited disorders and complex human diseases, DNA
library preparation, paired ends and genomic captures,
sequencing of mitochondrial genome and personal
genomics etc. It is anticipated that HT-NGS technology,
for clinical purposes in human medicine and implementa-
tion of genomic selection in farm animals breeding
programs will probably be fully adopted in the next couple
of decades. The recent technological advancements in HT-
NGS analysis is not only setting the benchmark in the
advancement in genomics researches but also in the fields
of proteomics, other omics and cancer research at a
unprecedented pace (e.g., DNA and protein microarrays,
quantitative PCR, mass spectrometry and others). Al-
though, the HT-NGS with short DNA sequence reads (25–
50 bases) and moderate sequence reads (500 bases) have
already found many potential applications, but for genomic
sequencing and for analysis of the ever more important
structural genetic variations in genomes, such as copy
number variations, chromosomal translocations, inversions,
large deletions, insertions and duplications, it would be a
great advantage if sequence read length on the original
single DNA molecule could be increased to several 1000
bases and more per second. With the progress of third NGS
platform at tremendous pace, one can hope that the goal of
determining a whole chromosome sequence from a single
original DNA molecule or genome sequence for $1000
could be feasible soon in the near future.
Table 4 (continued)
Domestic animals Description References
Genome assembly and analysis of domestic turkey: approximately 5x and 25x genome
coverages of domestic turkey were generated through Roche FLX and Illumina HT-NGS
platforms. A total of 28,261 scaffolds containing 917 Mb of sequence were also assigned to
turkey chromosomes.
Dalloul et al. 2010
Horse (Equus
ferus caballus)
HT-NGS database: Upgrading the equine functional annotation database for the emerging
equine NGS database.
Bright et al. 2009
Equine mRNA sequencing by Illumina NGS platform: RNA-seq from eight equine tissues
generated 293 758 105 sequence tags of 35bases each, equalling 10.28 gbp of total sequence
data. The tag alignments represent approximately 207× coverage of the equine mRNA
transcriptome and confirmed transcriptional activity for roughly 90% of the protein-coding
gene structures predicted by Ensembl and NCBI. Study utilized the Ensembl and NCBI
annotation pipelines to combine the 75 116 RNA-seq-derived transcriptional units and
generated a consensus equine protein-coding gene with a set of 20 302 defined loci.
Coleman et al. 2010
Sheep (Ovis aries) The construction of a reference genome of sheep: Initiated by international Sheep Genomics
Consortium, a draft reference genome of sheep was constructed utilizing NGS data together
with Sanger sequencing data.
Archibald et al. 2010
Giant Panda
(Ailuropoda
melanoleuca)
Classical example of De Novo sequencing: Using HT-NGS technology alone, study
successfully generated and assembled a draft sequence of the giant panda genome with the
assembled contigs of 2.25 gigabases (Gb) cover approximately 94% of the whole genome.
Li et al. 2010b
General review A comprehensive review on domestic animal genomics: paper summarizes the proceedings of
the USDA animal genomics workshop “Charting the road map for long term USDA efforts in
agricultural animal genomics” in which future target goals such as: priorities for structural and
functional genomics, bioinformatics resources in domestic animal genomics were discussed.
Green et al. 2007
A comprehensive review on vertebrate experimental organisms: an overview of the current
next-generation sequencing platforms and the newest computational tools for the analysis of
next-generation sequencing data in the context of vertebrate model organism genetics were
disccued.
Turner et al. 2009
A comprehensive review of HT-NGS technology applied to domestic animals: The review
paper discussed the experimental design, RNA-seq, computational approach for whole genome
sequence association studies, as opposed to classical SNP-based association, and implement-
ing this new source of information into breeding programs.
Pérez-Enciso and
Ferretti 2010
A comprehensive review on profiling of regulatory microRNA transcriptomes in various
biological processes: review highlighted the application of miRNA, particularly in regular
biological and pathological processes within cells and tissues and as a potential tool for
cellular control of gene regulation studies in human and animal genome researches.
Shah et al. 2010
J Appl Genetics (2011) 52:413–435 431Open Access This article is distributed under the terms of the Creative
Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
References
Ahn SM, Kim TH, Lee S, Kim D, Ghang H, Kim DS et al. (2009) The
first Korean genome sequence and analysis: full genome
sequencing for a socio-ethnic group. Genome Res 19:1622–1629
Amaral AJ, Megens HJ, Kerstens HH, Heuven HC, Dibbits B,
Crooijmans RP, den Dunnen JT, Groenen MA (2009) Application
of massive parallel sequencing to whole genome SNP discovery
in the porcine genome. BMC Genomics 10:374
Amstutz U, Andrey-Zürcher G, Suciu D, Jaggi R, Häberle J, Largiadèr
CR (2011) Sequence capture and next-generation resequencing of
multiple tagged nucleic acid samples for mutation screening of
urea cycle disorders. Clin Chem 57:102–111
Andersson L, Haley CS, Ellegren H, Knott SA et al. (1994) Genetic
mapping of quantitative trait loci for growth and fatness in pigs.
Science 263:1771–1774
Ansorge W et al. (1986) A non-radioactive automated method for
DNA sequence determination. J Biochem Biophys Methods
13:315–323
Ansorge W et al. (1987) Automated DNA sequencing: ultrasensitive
detection of fluorescent bands during electrophoresis. Nucleic
Acids Res 15:4593–4602
Archibald AL, Cockett NE, Dalrymple BP, International Sheep
Genomics Consortium et al. (2010) The sheep genome reference
sequence: a work in progress. Anim Genet 41:449–453.
doi:10.1111/j.1365-2052.2010.02100.x
Astier Y, Braha O, Bayley H (2006) Toward Single Molecule DNA
Sequencing: Direct Identification of Ribonucleoside and Deoxy-
ribonucleoside 5’-Monophosphates by Using an Engineered
Protein Nanopore Equipped with a Molecular Adapter. J Am
Chem Soc 128:1705–1710
Bansal V (2010) A statistical method for the detection of variants from
next-generation resequencing of DNA pools. Bioinformatics 26:
i318–i324
Bashamboo A, Ledig S, Wieacker P, Achermann JC, McElreavey K
(2010) New technologies for the identification of novel genetic
markers of disorders of sex development (DSD). Sex Dev 4:213–
224
Bell CJ, Dinwiddie DL, Miller NA, Hateley SL et al. (2011) Carrier
testing for severe childhood recessive diseases by next-generation
sequencing. Sci Transl Med 3:65ra4
Bhaijee F, Pepper DJ, Pitman KT, Bell D (2011) New developments in
the molecular pathogenesis of head and neck tumors: a review of
tumor-specific fusion oncogenes in mucoepidermoid carcinoma,
adenoid cystic carcinoma, and NUT midline carcinoma. Ann
Diagn Pathol 15:69–77
Bormann G, Chung CA, Boyd VL, McKernan KJ, Fu Y, Monighetti C,
PeckhamHE,BarkerM(2010)Wholemethylomeanalysisbyultra-
deep sequencing using two-base encoding. PLoS One 5:e9320
Bowne SJ, Sullivan LS, Koboldt DC, Ding L et al. (2011)
Identification of disease-causing mutations in autosomal domi-
nant retinitis pigmentosa (adRP) using next-generation DNA
sequencing. Invest Ophthalmol Vis Sci 52:494–503
Braslavsky I, Hebert B, Kartalov E, Quake SR (2003) Sequence
information can be obtained from single DNA molecules. Proc
Natl Acad Sci USA 100:3960–3964
Bright LA, Burgess SC, Chowdhary B, Swiderski CE, McCarthy FM
(2009) Structural and functional-annotation of an equine whole
genome oligoarray. BMC Bioinforma 11:S8
Buermans HP, Ariyurek Y, van Ommen G et al. (2010) New methods
for next generation sequencing based microRNA expression
profiling. BMC Genomics 11:716
Burgess DJ (2011) Human Disease: Next-generation sequencing of the
next generation. Nat Rev Genet 12:78–79
Burt D, (2006) The Chicken Genome. In: Vertebrate Genomes, Volff J-
N (ed). Genome Dyn. Karger 2:123–137
Chowdhary B, Raudsepp T (2006) The Horse Genome. In: Vertebrate
Genomes, Volff J-N (ed). Genome Dyn. Karger 2:97–110
Cockett N (2006) The Sheep Genome. In: Vertebrate Genomes, Volff
J-N (ed). Genome Dyn. Karger, 2:79–85
Coleman SJ, Zeng Z, Wang K, Luo S, Khrebtukova I, Mienaltowski
MJ, Schroth GP, Liu J, MacLeod JN (2010) Structural annotation
of equine protein-coding genes determined by mRNA sequenc-
ing. Anim Genet 41:121–130
Collins FS, Green ED, Guttmacher AE, Guyer MS (2003) Avision for
the future of genomics research. Nature 422:835–847
Costa V, Gallo MA, Letizia F, Aprile M, Casamassimi A, Ciccodicola A
(2010a)PPARG:GeneExpressionRegulationandNext-Generation
Sequencing for Unsolved Issues. PPAR Res 2010:409168
Costa V, Angelini C, De Feis I, Ciccodicola A (2010b) Uncovering the
complexity of transcriptomes with RNA-Seq. J Biomed Bio-
technol 2010:853916
Dalloul RA, Long JA, Zimin AV, Aslam L, Beal K et al. (2010) Multi-
platform next-generation sequencing of the domestic turkey
(Meleagris gallopavo): genome assembly and analysis. PLoS
Biol 8:e1000475
Dames S, Durtschi J, Geiersbach K, Stephens J, Voelkerding KV
(2010) Comparison of the Illumina Genome Analyzer and Roche
454 GS FLX for resequencing of hypertrophic cardiomyopathy-
associated genes. J Biomol Tech 21:73–80
Day-Williams AG, Zeggini E (2010) The effect of next-generation
sequencing technology on complex trait research. Eur J Clin
Invest. doi:10.1111/j.1365-2362.2010.02437.x
Ding L, Wendl MC, Koboldt DC, Mardis ER (2010) Analysis of next-
generation genomic data in cancer: accomplishments and
challenges. Hum Mol Genet 19:R188–R196
Drögemüller C, Tetens J, Sigurdsson S, Gentile A, Testoni S,
Lindblad-Toh K, Leeb T (2010) Identification of the bovine
Arachnomelia mutation by massively parallel sequencing impli-
cates sulfite oxidase (SUOX) in bone development. PLoS Genet
6:e1001079
Durbin RM, Abecasis GR, Altshuler DL, The 1000 Genomes Project
Consortium et al. (2010) A map of human genome variation from
population-scale sequencing. Nature 467:1061–1073
Eck SH, Benet-Pagès A, Flisikowski K, Meitinger T, Fries R, Strom TM
(2009) Whole genome sequencing of a single Bos taurus animal for
single nucleotide polymorphism discovery. Genome Biol 10:R82
Edwards A et al. (1990) Automated DNA sequencing of the human
HPRT locus. Genomics 6:593–608
Edwards CJ, Magee DA, Park SD, McGettigan PA et al. (2010) A
complete mitochondrial genome sequence from a mesolithic wild
aurochs (Bos primigenius). PLoS One 5:e9255
Eid J, Fehr A, Gray J, Luong K, Lyle J, Otto G et al. (2009) Real-time
DNA sequencing from single polymerase molecules. Science
323:133–138
Elsik CG, Tellam RL et al. (2009) The genome sequence of taurine
cattle: a window to ruminant biology and evolution. Science
324:522–528
Erhard F, Zimmer R (2010) Classification of ncRNAs using position
and size information in deep sequencing data. Bioinformatics 26:
i426–i432
Euskirchen GM, Rozowsky JS, Wei CL et al. (2007) Mapping of
transcription factor binding regions in mammalian cells by ChIP:
comparison of array- and sequencing-based technologies. Ge-
nome Res 17:898–909
432 J Appl Genetics (2011) 52:413–435Fang X, Yoon JG, Li L, Yu W, Shao J, Hua D, Zheng S, Hood L,
Goodlett DR, Foltz G, Lin B (2011) The SOX2 response program
in glioblastoma multiforme: an integrated ChIP-seq, expression
microarray, and microRNA analysis. BMC Genomics 12:11
Farias-Hesson E, Erikson J, Atkins A, Shen P, Davis RW, Scharfe C,
Pourmand N (2010) Semi-automated library preparation for high-
throughput DNA sequencing platforms. J Biomed Biotechnol
2010:617469
Fouse SD, Nagarajan RP, Costello JF (2010) Genome-scale DNA
methylation analysis. Epigenomics 2:105–117
Galibert F, André C, (2006) The Dog Genome. In: Vertebrate
Genomes, Volff J-N (ed). Genome Dyn. Karger, 2:46–59
Georges M, Nielsen D, Mackinnon M, Mishra A, Okimoto R et al.
(1995) Mapping Quantitative Trait Loci Controlling Milk
Production in Dairy Cattle by Exploiting Progeny Testing.
Genetics 139:907–920
Gibbs R, Weinstock G, Rohrer G, Kappes S, Schook L, Skow L,
Womack J (2002) Bovine genomic sequencing initiative Cattle-
izing the human genome. Bovine sequencing white paper. pp: 1–
12. http://www.genome.gov/pages/research/sequencing/
seqproposals/bovineseq.pdf
Green RD, Qureshi MA, Long JA, Burfening PJ, Hamernik DL (2007)
Identifying the Future Needs for Long-Term USDA Efforts in
Agricultural Animal Genomics. Int J Biol Sci 3:185–191
Greenleaf WJ, Block SM (2006) Single-molecule, motion-based DNA
sequencing using RNA polymerase. Science 313:801
GrisartB,CoppietersW,FarnirF,KarimL,FordCetal.(2001)Positional
candidate cloning of a QTL in dairy cattle: Identification of a
missense mutation in the bovine DGAT1 gene with major effect on
milk yield and composition. Genome Res 12:222–231
Hackenberg M, Barturen G, Oliver JL, Smeth NG (2011) A database
for next-generation sequencing single-cytosine-resolution DNA
methylation data. Nucleic Acids Res 39:D75–D79
Hajirasouliha I, Hormozdiari F, Alkan C, Kidd JM, Birol I, Eichler EE,
Sahinalp SC (2010) Detection and characterization of novel
sequence insertions using paired-end next-generation sequencing.
Bioinformatics 26:1277–1283
Harris TD, Buzby PR, Babcock H, Beer E, Bowers J, Braslavsky I,
Causey M et al. (2008) Single-molecule DNA sequencing of a
viral genome. Science 320:106–109
Henn BM, Gravel S, Moreno-Estrada A, Acevedo-Acevedo S,
Bustamante CD (2010) Fine-scale population structure and the
era of next-generation sequencing. Hum Mol Genet 19:R221–
R226
Hestand MS, Klingenhoff A, Scherf M, Ariyurek Y et al. (2010)
Tissue-specific transcript annotation and expression profiling
with complementary next-generation sequencing technologies.
Nucleic Acids Res 38:e165
Hillier LW, Miller W, Birney E, Warren W, International Chicken
Genome Sequencing Consortium et al. (2004) Sequence and
comparative analysis of the chicken genome provide unique
perspectives on vertebrate evolution. Nature 432:695–716
Hong D, Park SS, Ju YS, Kim S, Shin JY et al. (2011) TIARA: a
database for accurate analysis of multiple personal genomes
based on cross-technology. Nucleic Acids Res 39:D883–D888
Isom SC, Spollen WG, Blake SM, Bauer BK, Springer GK, Prather
RS (2010) Transcriptional profiling of day 12 porcine embryonic
disc and trophectoderm samples using ultra-deep sequencing
technologies. Mol Reprod Dev 77:812–819
Jex AR, Hall RS, Littlewood DT, Gasser RB (2010) An integrated
pipeline for next-generation sequencing and annotation of
mitochondrial genomes. Nucleic Acids Res 38:522–533
Jiao S, Bailey CP, Zhang S, Ladunga I (2010) Probabilistic peak
calling and controlling false discovery rate estimations in
transcription factor binding site mapping from ChIP-seq. Meth-
ods Mol Biol 674:161–177
Katsios C, Ziogas DE, Liakakos T, Zoras O, Roukos DH (2010)
Translating Cancer Genomes Sequencing Revolution into Surgi-
cal Oncology Practice. J Surg Res. doi:10.1016/j.jss.2010.10.038
Kedes L, Liu E, Jongeneel CV, Sutton G (2011) Judging the Archon
Genomics X PRIZE for whole human genome sequencing.
Nature Genet 43:175
Kim JI, Ju YS, Park H, Kim S, Lee S, Yi JH, Mudge J, Miller NA et
al. (2009) A highly annotated whole-genome sequence of a
Korean individual. Nature 460:1011–1015
Kingsley CB (2011) Identification of causal sequence variants of
disease in the next generation sequencing era. Methods Mol Biol
700:37–46
Kuhlenbäumer G, Hullmann J, Appenzellerm S (2011) Novel genomic
techniques open new avenues in the analysis of monogenic
disorders. Hum Mutat 32:144–151
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J,
Devon K, Dewar K et al. (2001) Initial sequencing and analysis
of the human genome. Nature 409:860–921
Leary RJ, Kinde I, Diehl F, Schmidt K, Clouser C, Duncan C et al.
(2010) Development of personalized tumor biomarkers using
massively parallel sequencing. Sci Transl Med 2:20ra14
Lee LW, Zhang S, Etheridge A, Ma L, Martin D, Galas D, Wang K
(2010) Complexity of the microRNA repertoire revealed by next-
generation sequencing. RNA 16:2170–2180
Leifer I, Hoffmann B, Höper D, Bruun Rasmussen T, Blome S,
Strebelow G, Höreth-Böntgen D, Staubach C, Beer M (2010)
Molecular epidemiology of current classical swine fever virus
isolates of wild boar in Germany. J Gen Virol 91:2687–2697
Levene MJ, Korlach J, Turner SW, Foquet M, Craighead HG, Webb
WW (2003) Zero-mode waveguides for single-molecule analysis
at high concentrations. Science 299:682–686
Li R, Zhu H, Ruan J, Qian W, Fang X et al. (2010a) de novo assembly
of human genomes with massively parallel short read sequenc-
ing. Genome Res 20:265–272
Li R, Fan W, Tian G, Zhu H, He L, Cai J et al. (2010b) The sequenceand
de novo assembly of the giant panda genome. Nature 463:311–317
Lind C, Ferriola D, Mackiewicz K, Heron S, Rogers M et al. (2010)
Next-generation sequencing: the solution for high-resolution,
unambiguous human leukocyte antigen typing. Hum Immunol
71:1033–1042
Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB et
al. (2005) Genome sequence, comparative analysis and haplotype
structure of the domestic dog. Nature 438:803–819
Liu GE (2009) Applications and case studies of the next-generation
sequencing technologies in food, nutrition and agriculture.
Recent Pat Food Nutr Agric 1:75–79
Liu Y, Qin X, Henry Song X et al. (2009) Bos taurus genome
assembly. BMC Genomics 10:180
Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC et
al. (2010) Whole-genome sequencing in a patient with Charcot-
Marie-Tooth neuropathy. N Engl J Med 362:1181–1191
MacHugh DE, Gormley E, Park SD, Browne JA, Taraktsoglou M,
O'Farrelly C, Meade KG (2009) Gene expression profiling of the
host response to Mycobacterium bovis infection in cattle.
Transbound Emerg Dis 56:204–214
Mardis ER (2008a) Next-generation DNA sequencing methods. Annu
Rev Genomics Hum Genet 9:387–402
Mardis ER (2008b) The impact of next-generation sequencing
technology on genetics. Trends Genet 3:133–141
Mardis ER (2009) New strategies and emerging technologies for
massively parallel sequencing: applications in medical research.
Genome Med 1:40
Mardis ER (2010) The $1,000 genome, the $100,000 analysis?
Genome Med 2:84
Mardis ER (2011) A dacade’s perspective on DNA sequencing
technology. Nature 470:198–203
J Appl Genetics (2011) 52:413–435 433Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S et al. (2009)
Transcriptome sequencing to detect gene fusions in cancer.
Nature 458:97–101
Marguerat S, Bähler J (2010) RNA-seq: from technology to biology.
Cell Mol Life Sci 67:569–579
Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben
LA, Berka J et al. (2005) Genome sequencing in microfabricated
high-density picolitre reactors. Nature 437:376–380
Marklund S, Carlborg O (2010) SNP detection and prediction of
variability between chicken lines using genome resequencing of
DNA pools. BMC Genomics 11:665
Maxam AM, Gilbert W (1977) A new method for sequencing DNA.
Proc Natl Acad Sci USA 74:560–564
McBride DJ, Orpana AK, Sotiriou C, Joensuu H, Stephens PJ et al.
(2010) Use of cancer-specific genomic rearrangements to
quantify disease burden in plasma from patients with solid
tumors. Genes Chromosomes Cancer 49:1062–1069
McComish BJ, Hills SF, Biggs PJ, Penny D (2010) Index-free de novo
assembly and deconvolution of mixed mitochondrial genomes.
Genome Biol Evol 2:410–424
McKernan KJ, Peckham HE, Costa GL, McLaughlin SF, Fu Y et al.
(2009) Sequence and structural variation in a human genome
uncovered by short-read, massively parallel ligation sequencing
using two-base encoding. Genome Res 19:1527–1541
Metzker ML (2010) Sequencing technologies- the next generation.
Nat Rev Genet 1:31–46
Meyerson M, Gabriel S, Getz G (2010) Advances in understanding
cancer genomes through second-generation sequencing. Nat Rev
Genet 11:685–696
Michelizzi VN, Dodson MV, Pan Z, Amaral ME, Michal JJ, McLean
DJ, Womack JE, Jiang Z (2010) Water buffalo genome science
comes of age. Int J Biol Sci 6:333–349
Michelizzi VN, Wu X, Dodson MV, Michal JJ, Zambrano-Varon J,
McLean DJ, Jiang Z (2011) A Global View of 54,001 Single
Nucleotide Polymorphisms (SNPs) on the Illumina Bovi-
neSNP50 BeadChip and their transferability to Water Buffalo.
Int J Biol Sci 7:18–27
Mitra RD et al. (2003) Digital genotyping and haplotyping with
polymerase colonies. Proc Natl Acad Sci USA 100:5926–5931
Moore G (1965) Cramming more components onto integrated circuits.
Electronics 38
Morin RD, Zhao Y, Prabhu AL, Dhalla N, McDonald H, Pandoh P,
Tam A, Zeng T, Hirst M, Marra M (2010) Preparation and
analysis of microRNA libraries using the Illumina massively
parallel sequencing technology. Methods Mol Biol 650:173–199
Mote B, Rothschild M (2006) Cracking the genomic piggy bank:
Identifying secrets of the pig genome. In: Vertebrate Genomes,
Volff J-N (ed). Genome Dyn. Karger, 2:86–96
Murphy W (2006) The Feline Genome. In: Vertebrate Genomes, Volff
JN (ed). Genome Dyn. Karger, 2:60–68
Nagalakshmi U, Waern K, Snyder M (2010) RNA-Seq: a method for
comprehensive transcriptome analysis. Curr Protoc Mol Biol
Chapter 4(Unit 4.11):1–13
Nagarajan N, Pop M (2010) Sequencing and genome assembly using
next-generation technologies. Methods Mol Biol 673:1–17
Neff T, Armstrong SA (2009) Chromatin maps, histone modifications
and leukemia. Leukemia 23:1243–1251
Nyren et al. (1993) Solid phase DNA minisequencing by an enzymatic
luminometric inorganic pyrophosphate detection assay. Anal
Biochem 208:171–175
Nyren P (2007) The history of pyrosequencing. Methods Mol Biol
373:1–14
Ozsolak F, Kapranov P, Foissac S, Kim SW, Fishilevich E, Monaghan
AP, John B, Milos PM (2010) Comprehensive polyadenylation
site maps in yeast and human reveal pervasive alternative
polyadenylation. Cell 143:1018–1029
Ozsolak F, Milos PM (2011a) RNA sequencing: advances, challenges
and opportunities. Nat Rev Genet 12:87–98
Ozsolak F, Milos PM (2011b) Transcriptome profiling using single-
molecule direct RNA sequencing. Methods Mol Biol 733:51–61
Pérez-Enciso M, Ferretti L (2010) Massive parallel sequencing in
animal genetics: wherefroms and wheretos. Anim Genet 41:561–
569. doi:10.1111/j.1365-2052.2010.02057.x
Pfeifer GP, Hainaut P (2011) Next-generation sequencing: emerging
lessons on the origins of human cancer. Curr Opin Oncol 23:62–
68
Pontius JU, Mullikin JC, Smith DR, Lindblad-Tohet K, Team AS et al.
(2007) Initial sequence and comparative analysis of the cat
genome. Genome Res 17:1675–1689
Pool R, Waddell K (2002) Exploring horizons for domestic animal
genomics. Workshop summary. National Academic Press, Con-
stitution Avenue, NW, Washington, D.C. (www.nap.edu).
Popp C, Dean W, Feng S, Cokus SJ, Andrews S, Pellegrini M,
Jacobsen SE, Reik W (2010) Genome-wide erasure of DNA
methylation in mouse primordial germ cells is affected by AID
deficiency. Nature 463:1101–1105
Pushkarev D, Neff NF, Quake SR (2009) Single-molecule sequencing
of an individual human genome. Nat Biotechnol 27:847–850
Ramos AM, Crooijmans RP, Affara NA, Amaral AJ, Archibald AL et
al. (2009) Design of a high density SNP genotyping assay in the
pig using SNPs identified and characterized by next generation
sequencing technology. PLoS One 4:e6524
Ramsingh G, Koboldt DC, Trissal M, Chiappinelli KB et al. (2010)
Complete characterization of the microRNAome in a patient with
acute myeloid leukemia. Blood 116:5316–5326
Raymond FL, Whittaker J, Jenkins L, Lench N, Chitty LS (2010)
Molecular prenatal diagnosis: the impact of modern technologies.
Prenat Diagn 30:674–681
Robertson G, Hirst M, Bainbridge M et al. (2007) Genome-wide profiles
of STAT1 DNA association using chromatin immunoprecipitation
and massively parallel sequencing. Nat Methods 4:651–657
Rohrer G, Beever JE, Rothschild MF, Schook L, Gibbs R, Weinstock
G (2002) Porcine genomic sequencing initiative. Porcine se-
quencing white paper. pp: 1–10. http://www.genome.gov/Pages/
Research/Sequencing/SeqProposals/PorcineSEQ021203.pdf
Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P (1996)
Real-time DNA sequencing using detection of pyrophosphate
release. Anal Biochem 242:84–89
Ronaghi M, Uhlen M, Nyren P (1998) A sequencing method based on
real-time pyrophosphate. Science 281:363–365
Rusk N (2009) Cheap third-generation sequencing. Nat Methods
6:244–245
Sanger F (1975) The Croonian Lecture, 1975: Nucleotide Sequences
in DNA, B191 Proc. Royal Soc, London, 317
Sanger F, Coulson AR (1975) A rapid method for determining
sequences in DNA by primed synthesis with DNA polymerase.
J Mol Biol 94:441–448
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-
terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Schadt EE, Turner S, Kasarskis A (2010) A window into third-
generation sequencing. Hum Mol Genet 19:R227–R240
Schuster SC et al. (2008) Method of the year, next-generation DNA
sequencing: Functional genomics and medical applications, Nat.
Methods 5:11–21
Selvin PR (2000) The renaissance of fluorescence resonance energy
transfer. Nat Struct Biol 7:730–734
Senapathy P, Bhasi A, Mattox J, Dhandapany PS, Sadayappan S
(2010) Targeted genome-wide enrichment of functional regions.
PLoS One 5:e11138
Shah AA, Meese E, Blin N (2010) Profiling of regulatory microRNA
transcriptomes in various biological processes. a review. J Appl
Genet 51:501–507
434 J Appl Genetics (2011) 52:413–435Shapiro B, Hofreiter M (2010) Analysis of ancient human genomes:
using next generation sequencing, 20-fold coverage of the
genome of a 4,000-year-old human from Greenland has been
obtained. BioEssays 32:388–391
Shendure J, Porreca GJ, Reppas NB, Lin X, McCutcheon JP et al.
(2005) Accurate multiplex polony sequencing of an evolved
bacterial genome. Science 309:1728–1732
Singleton AB, Hardy J, Traynor BJ, Houlden H (2010) Towards a
complete resolution of the genetic architecture of disease. Trends
Genet 26:438–442
Smith LM et al. (1986) Fluorescence detection in automated DNA
sequence analysis. Nature 321:674–679
Soroka M, Burzynski A (2010) Complete sequences of maternally
inherited mitochondrial genomes in mussels Unio pictorum
(Bivalvia, Unionidae). J Appl Genet 51:469–476
Sutton G, Liu E, and Jongeneel CV. Kedes L (2011) Archon genomics
XPRIZEvalidationprotocol.NaturePreceedings(http://precedings.
nature.com/documents/5731/version/1).
Tawfik DS, Griffiths AD (1998) Man-made cell-like compartments for
molecular evolution. Nature Biotech 16:652–656
Turner DJ, Keane TM, Sudbery I, Adams DJ (2009) Next-generation
sequencing of vertebrate experimental organisms. Mamm Ge-
nome 20:327–338
Van Tassell CP, Smith TPL, Matukumalli LK, Taylor JF, Schnabel RD
et al. (2008) SNP discovery and allele frequency estimation by
deep sequencing of reduced representation libraries. Nat Methods
5:247–252
Van Laere AS, Nguyen M, Braunschweig M, Nezer C, Collette C,
Moreau L, Archibald AL, Haley CS, Buys N, Tally M,
Andersson G, Georges M, Andersson L (2003) A regulatory
mutation in IGF2 causes a major QTL effect on muscle growth in
the pig. Nature 425:832–836
Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG,
Smith HO et al. (2001) The sequence of the human genome.
Science 291:1304–1351
Vermeer S, Hoischen A, Meijer RP, Gilissen C, Neveling K et al. (2010)
Targeted next-generation sequencing of a 12.5 Mb homozygous
region reveals ANO10 mutations in patients with autosomal-
recessive cerebellar ataxia. Am J Hum Genet 87:813–819
Voelkerding KV, Dames S, Durtschi JD (2010) Next generation
sequencing for clinical diagnostics-principles and application to
targeted resequencing for hypertrophic cardiomyopathy: a paper
from the 2009 William Beaumont Hospital Symposium on
Molecular Pathology. J Mol Diagn 12:539–551
Wade CM, Giulotto E, Sigurdsson S, Zoli M, Gnerre S et al. (2009)
Genome sequence, comparative analysis, and population genetics
of the domestic horse. Science 326:865–867
Walsh T, Lee MK, Casadei S, Thornton AM, Stray SM, Pennil C,
Nord AS, Mandell JB, Swisher EM, King MC (2010) Detection
of inherited mutations for breast and ovarian cancer using
genomic capture and massively parallel sequencing. Proc Natl
Acad Sci USA 107:12629–12633
Wang J, Wang W, Li R, Li Y, Tian G, Goodman L, Fan W, Zhang J et
al. (2008) The diploid genome sequence of an Asian individual.
Nature 456:60–65
Wang WC, Lin FM, Chang WC, Lin KY, Huang HD, Lin NS (2009)
miRExpress: analyzing high-throughput sequencing data for
profiling microRNA expression. BMC Bioinforma 10:328
Werner T (2010) Next generation sequencing in functional genomics.
Brief Bioinform 11:499–511
Wernersson R, Schierup MH, Jørgensen FG, Gorodkin J, Panitz F
et al. (2005) Pigs in sequence space: A 0.66× coverage pig
genome survey based on shotgun sequencing. BMC Genomics
6:70
Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, McGuire A
et al. (2008) The complete genome of an individual by massively
parallel DNA sequencing. Nature 452:872–876
Whiteford N, Skelly T, Curtis C, Ritchie ME, Löhr A, Zaranek AW,
Abnizova I, Brown C (2009) Swift: primary data analysis for the
Illumina Solexa sequencing platform. Bioinformatics 25:2194–
2199
Wiedmann RT, Smith TP, Nonneman DJ (2008) SNP discovery in
swine by reduced representation and high throughput pyrose-
quencing. BMC Genet 9:81
Womack J (2006) The Bovine Genome. In: Vertebrate Genomes, Volff
JN (ed). Genome Dyn. Karger 2:69–78
Wright CF, Morelli MJ, Thébaud G, Knowles NJ, Herzyk P, Paton DJ,
Haydon DT, King DP (2011) Beyond the consensus: dissecting
within-host viral population diversity of foot-and-mouth disease
virus using next-generation genome sequencing. J Virol 85:2266–
2275
Xi R, Kim TM, Park PJ (2010) Detecting structural variations in the
human genome using next generation sequencing. Brief Funct
Genomics 9:405–415
Yamey G (2000) Scientists unveil first draft of human genome. BMJ
321:7
Yang JH, Shao P, Zhou H, Chen YQ, Qu LH (2011) deepBase: a
database for deeply annotating and mining deep sequencing data.
Nucleic Acids Res 38:D123–D130
Zimin AV, Delcher AL, Florea L, Kelley DR et al. (2009) A whole-
genome assembly of the domestic cow. Bos Taurus Genome Biol
10:R42. doi:10.1186/gb-2009-10-4-r42
Zoghbi HY, Warren ST (2010) Neurogenetics: advancing the "next-
generation" of brain research. Neuron 68:165–173
J Appl Genetics (2011) 52:413–435 435